Why menopause hormone therapy cannot be a one-size-fits-all fix

Did you know that menopause can cover about 40% of a woman's entire lifespan? It is not just a brief pause. This major biological transition involves up to 72 distinct symptoms, shaping aging trajectories, the patterns of how organs age over time.

A diverse biological shift

Health outcomes and later-life disease risks depend directly on the specifics of this change. The transition timing, its type, and the total symptom burden all alter how different body systems age. Because so much of life is lived after menopause, managing these changes effectively is vital for long-term health.

More than two hundred choices

Many discussions treat menopause hormone therapy as a single, uniform drug. In reality, it comes in over 200 distinct varieties. These options differ in their timing, dosage, and specific blends of estrogens and progestogens, which are hormones paired with estrogen.

Think of these treatments like motor vehicles. Calling every option the same medicine is like pretending an electric scooter, a family car, and a heavy lorry all handle identically. However, this comparison stops working when you consider biology: unlike driving a vehicle, our bodies react unpredictably based on genetics and personal medical histories.

Because each variety carries a unique balance of benefits and risks, doctors must rely on precision medicine. This approach tailors care directly to individual traits rather than handing out a generic fix. Yet, past scientific literature has often lumped these diverse options together, missing critical differences.

What we still do not know

Scientific research currently lacks enough data on managing symptoms and optimizing postmenopausal health. Scientists do not yet know how to fully match someone's specific genetics, past hormone exposures, and symptoms to the ideal choice among those 200 options. Finding comprehensive strategies to support healthy aging for everyone remains an active challenge.